Skip to main content Skip to section navigation Skip to footer
Vivani Medical, Inc.
  • Investors
  • IR Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Our Company
    • Overview
    • Executive Leadership
    • Code of Ethics
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Annual Reports & Proxy Statements
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
    • Privacy

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
      Feb 28, 2024 8:30am EST

      Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

      Nov 14, 2023 6:00am EST

      Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

      Oct 16, 2023 6:00am EDT

      Vivani Medical to Present at BIO Investor Forum

      Sep 07, 2023 6:00am EDT

      Vivani Medical to Present at the Boulder Peptide Symposium

      Sep 05, 2023 6:00am EDT

      Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

      Aug 14, 2023 5:45pm EDT

      Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

      Jul 11, 2023 6:00am EDT

      Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

      Jun 14, 2023 6:00am EDT

      Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

      May 15, 2023 6:15am EDT

      Vivani Medical Reports First Quarter Financial Results and Provides Business Update

      Apr 04, 2023 6:00am EDT

      Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study

      • Previous Pagearrow_back
      • Page 1
      • Page 2
      • Page 3
      • Page 4
      • Page 5
      • Page 6
      • Page 7
      • Page 8
      • Page 9
      • Page 10
      • …
      • Page 20
      • Next Pagearrow_forward
      rss_feed News RSS
      • Email Alerts
      • Contacts
      • RSS News Feed
      ©2025 Vivani Medical, Inc. All Rights Reserved.
      Privacy Policy Disclaimer Sitemap